SEC Comment Letter for ALTERITY THERAPEUTICS LTD (ATHE, PRNAF) (CIK 0001131343) (ATHE) — Dec 29, 2020
ALTERITY THERAPEUTICS LTD (ATHE, PRNAF) (CIK 0001131343)
Date: Dec. 29, 2020 · CIK: 0001131343 · Accession: 0000000000-20-012533
AI Filing Summary & Sentiment
File numbers found in text: 333-251647
Letter
United States securities and exchange commission logo December 29, 2020 Kathryn Andrews Chief Financial Officer ALTERITY THERAPEUTICS LTD ABN 37 080 699 065 Level 3, 460 Bourke Street Melbourne, Victoria 3000 Australia Re:ALTERITY THERAPEUTICS LTD Registration Statement on Form F-3 Filed December 23, 2020 File No. 333-251647 Dear Ms. Andrews: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Laura Crotty at 202-551-7614 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Steven J. Glusband
Show Raw Text
United States securities and exchange commission logo
December 29, 2020
Kathryn Andrews
Chief Financial Officer
ALTERITY THERAPEUTICS LTD
ABN 37 080 699 065
Level 3, 460 Bourke Street
Melbourne, Victoria 3000 Australia
Re:ALTERITY THERAPEUTICS LTD
Registration Statement on Form F-3
Filed December 23, 2020
File No. 333-251647
Dear Ms. Andrews:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Laura Crotty at 202-551-7614 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Steven J. Glusband